GlassScriptPhysician profile
Edward A Bittner
NPI 1215912456
$8,992.50
in general payments reported to CMS, 2019-2025
5 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $650 · 2021: $7,000 · 2023: $305 · 2024: $350 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,042.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics International LTD | $7,000.00 | 2021 | |
| Edwards Lifesciences Corporation | $700.00 | 2020-2024 | |
| Bard Peripheral Vascular, INC. | $687.50 | 2019-2025 | |
| Becton, Dickinson and Company | $305.00 | 2023 | |
| Bard Access Systems, INC. | $300.00 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Bittner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.